NCT01104428|UnknownPhase 2DMC
Loading search results
Sponsor study identifier
interventional
256
1 country
1
Study Start
November 2009
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2011
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
Not reported
Date not reportedDue to high incidence of renal damage by Hench-schonlein Purpura(HSP) is the key to affect prognosis, this project moves the research emphasis forward in line with the idea of "prevention of progress of disease", Which concerns on Traditional Chinese Medicine(TCM) clinical research scheme evaluation of HSP, evaluates the renal damage and disease recurrence as the end event, and comes to the evaluation through the comparative study that the vantage point of the scheme of syndrome differentiation and treatment in detoxification, cooling blood and removing blood stasis to the conventional treatments can reduce kidney damage and recurrence rate.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 2009
Date type not reportedThis date has not been verified as actual or estimated.
January 25, 2010
Actual (reported)April 15, 2010
Actual (reported)December 2011
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
whether endpoint such as renal damage or disease recurrence appears in the participants.
Endpoint is a mark of termination or completion. In this clinical research, the renal damage and disease recurrence that constitutes the target outcomes of the trial.
6 months
whether the TCM syndrome of participants disappears after treatment.
1 month
granules, \<10years,10g,Three times a day,take orally \>10years,20g,Three times a day,take orally fore weeks a period,Observe 2 periods
granules, \<10years,10g,Three times a day,take orally \>10years,20g,Three times a day,take orally fore weeks a period,Observe 2 periods
Zhangjun
Shenyang, Liaoning, 110032, China
zhang jun, master
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
zhao lijun, master
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
wang shaojie, master
Dalian Children's Hospital
ma liming, master
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
First Submitted
January 25, 2010
First Posted
April 15, 2010
Study Start
November 2009
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2011
Estimated (date passed)Efficacy of Steroid Versus Steroid Plus Cyclophosphamide for Severe Henoch-Schoenlein Purpura
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
li tienan, master
Shenyang Hospital of Integrated Traditional and westen Medicine
xu rongqian, master
Dongzhimen Hospital, Beijing
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
September 8, 2010
Record last verified: 2010-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: